Flu Vaccines

Flu Vaccines

We know that the 2018/19 flu season has been extremely challenging for our member practices because of the late NHS England policy change and the introduction of a new vaccine for your largest cohort.

That’s why we have made the decision to work with all four remaining flu vaccine companies for the 2019/20 season to ensure we are in a position to help our members no matter which supplier you decide to use next year. GSK and Pfizer will not be producing flu vaccines for the UK market for 2019/20 which leaves MASTA, Mylan, Sanofi and Seqirus.

Supplied by: MASTA, Mylan, Sanofi and Seqirus

« Back to all Products & Suppliers

2019-20 Offers

The Buying Group has negotiated discounts on all vaccines that are available to order as well as other terms such as sale or return, reserves, early delivery etc.

Since we launched our offers in October 2018, two new vaccines have been licensed for the UK market. On 23 January 2019, NHS England confirmed which vaccines can be used for the 2019-20 season:

  • Patients aged 65 and over: Adjuvanted Trivalent (ATIV) or the cell based quadrivalent (QIVc). Both vaccines are manufactured by Seqirus and will be reimbursed.
  • At risk groups/eligible adults aged 64 and under: egg based quadrivalent (QIVe) or the cell based quadrivalent (QIVc). QIVe vaccines are available from MASTA, Mylan and Sanofi. The QIVc is only available from Seqirus. Both the QIVe and QIVc vaccines will be reimbursed. Since we released our original offer information, Mylan has informed us that children aged 3-17 can now be given either of their QIVe vaccines.

The high-dose trivalent vaccine (TIV-HD), which JCVI also advised as equally suitable for use in those aged 65 years and over, has now been licensed for use in the UK but has a significantly higher list price than the equally suitable vaccines. This vaccine will not be commissioned by NHS England or reimbursed for use in the NHS Influenza vaccination programme in 2019/20.

Please read the latest updates from NHS England below for more information:

Published update 17 July 2019
Published update 23 January 2019

We will update Seqirus’ price list when they provide us with their discount structure for their QIVc vaccine.


We appreciate that some practices have been particularly concerned about early deliveries to pharmacy ahead of general practice. Our suppliers have offered reassurances that all providers will be treated exactly the same next year. We suggest that you ask your flu vaccine supplier for the earliest date that you can receive and start your clinics as early as possible if you are concerned about competition from pharmacies. The earlier you order the more likely you are to be able to secure deliveries in your chosen week.

If you have already been provided with a quote by any vaccine company, please make sure they are using the October 2018 dispensing fee scales otherwise your quote will be 36p a dose out as the fees have increased by this much since last year and that you have been given our discount.

Register or login to view the offers for 2019-20 as well as some of the additional resources we have produced.

The Buying Group team are happy to help you with any queries you might have about the vaccines available for 2019-20, the PPD, discounts and other terms and any other issues you may be experiencing.

Tel: 0115 979 6910
You can also email us or live chat with one of the team via this website.

Products & Services